These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 25841915)

  • 21. Local-regional treatment of hepatocellular carcinoma.
    Lencioni R; Crocetti L
    Radiology; 2012 Jan; 262(1):43-58. PubMed ID: 22190656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcatheter arterial chemoembolization combined with radiofrequency ablation for the treatment of hepatocellular carcinoma.
    Peng ZW; Chen MS
    Oncology; 2013; 84 Suppl 1():40-3. PubMed ID: 23428857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Recent Advance in Image-Guided Locoregional Therapy for Hepatocellular Carcinoma.
    Shi Y; Zhai B
    Gastrointest Tumors; 2016 Oct; 3(2):90-102. PubMed ID: 27904861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of combined percutaneous radio-frequency ablation and percutaneous ethanol injection after transcatheter arterial chemoembolization for hepatocellular carcinoma].
    Zhang FJ; Wu PH; Zhao M; Gu YK; Zhang L; Tan ZB
    Zhonghua Zhong Liu Za Zhi; 2005 Apr; 27(4):248-50. PubMed ID: 15949431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of intermediate/advanced hepatocellular carcinoma in the clinic: how can outcomes be improved?
    Lencioni R; Chen XP; Dagher L; Venook AP
    Oncologist; 2010; 15 Suppl 4():42-52. PubMed ID: 21115580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcome of regional and local ablative therapies for hepatocellular carcinoma: a collective review.
    Jansen MC; van Hillegersberg R; Chamuleau RA; van Delden OM; Gouma DJ; van Gulik TM
    Eur J Surg Oncol; 2005 May; 31(4):331-47. PubMed ID: 15837037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loco-regional interventional treatment of hepatocellular carcinoma: techniques, outcomes, and future prospects.
    Lencioni R; Crocetti L; De Simone P; Filipponi F
    Transpl Int; 2010 Jul; 23(7):698-703. PubMed ID: 20492618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of hepatocellular carcinoma combining sorafenib and transarterial locoregional therapy: state of the science.
    Weintraub JL; Salem R
    J Vasc Interv Radiol; 2013 Aug; 24(8):1123-34. PubMed ID: 23562168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Current therapy of hepatocellular carcinoma with special consideration of new and multimodal treatment concepts].
    Göbel T; Blondin D; Kolligs F; Bölke E; Erhardt A
    Dtsch Med Wochenschr; 2013 Jul; 138(27):1425-30. PubMed ID: 23801265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intermediate hepatocellular carcinoma: the role of transarterial therapy.
    Chegai F; Orlacchio A; Merolla S; Monti S; Mannelli L
    Hepat Oncol; 2015 Oct; 2(4):399-408. PubMed ID: 26998220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization.
    Raoul JL; Sangro B; Forner A; Mazzaferro V; Piscaglia F; Bolondi L; Lencioni R
    Cancer Treat Rev; 2011 May; 37(3):212-20. PubMed ID: 20724077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Transarterial chemoembolization (TACE) in hepatocellular carcinoma: technique, indication and results].
    Vogl TJ; Zangos S; Balzer JO; Nabil M; Rao P; Eichler K; Bechstein WO; Zeuzem S; Abdelkader A
    Rofo; 2007 Nov; 179(11):1113-26. PubMed ID: 17948190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic efficacy of multimodal combination therapy using transcatheter arterial infusion of epirubicin and cisplatin, systemic infusion of 5-fluorouracil, and additional percutaneous ethanol injection for unresectable hepatocellular carcinoma.
    Jang JW; Park YM; Bae SH; Choi JY; Yoon SK; Chang UI; Nam SW; Kim BS
    Cancer Chemother Pharmacol; 2004 Nov; 54(5):415-20. PubMed ID: 15235823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of sorafenib in intermediate-stage hepatocellular carcinoma patients refractory to transarterial chemoembolization.
    Ogasawara S; Chiba T; Ooka Y; Kanogawa N; Motoyama T; Suzuki E; Tawada A; Kanai F; Yoshikawa M; Yokosuka O
    Oncology; 2014; 87(6):330-41. PubMed ID: 25227534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hepatocellular carcinoma: percutaneous ethanol injection/transarterial chemoembolization/radiofrequency thermoablation].
    Allgaier HP; Rossi S; Deibert P; Zuber I; Hering M; Blum HE
    Praxis (Bern 1994); 2000 Jun; 89(24):1056-60. PubMed ID: 10902462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of the treatment response of HCC.
    Kim KW; Lee JM; Choi BI
    Abdom Imaging; 2011 Jun; 36(3):300-14. PubMed ID: 21279353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transarterial therapies for primary liver tumors.
    Talenfeld AD; Sista AK; Madoff DC
    Surg Oncol Clin N Am; 2014 Apr; 23(2):323-51. PubMed ID: 24560113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis.
    Wang W; Shi J; Xie WF
    Liver Int; 2010 May; 30(5):741-9. PubMed ID: 20331507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Percutaneous radiofrequency ablation combined with transcatheter arterial chemoembolization and percutaneous ethanol injection for recurrent small hepatocellular carcinoma].
    Xu ZM; Wang JH; Zhen ZJ; Chen HW; Cui WZ
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1626-8. PubMed ID: 17121718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intra-arterial therapies for hepatocellular carcinoma: where do we stand?
    Liapi E; Geschwind JF
    Ann Surg Oncol; 2010 May; 17(5):1234-46. PubMed ID: 20405328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.